People with Alzheimer's disease who took the common supplement glucosamine were 25% more likely to die within five years than those who didn't. That's the key finding of a new study that my colleagues and I published in the journal Nature Metabolism.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗